Raymond March Archive

Raymond J. March is a Research Fellow at the Independent Institute and Assistant Professor of Economics at San José State University. His research examines the public and private provision and governance of healthcare in the United States, particularly in pharmaceutical markets.

To Help the Terminally Ill, the FDA Must Deregulate



Right-to-try will never reach its potential without deregulation.

When Healthy Policy Neglects Economic Principles, Patients Suffer



Recent events indicate an urgent need for researchers and policymakers to relearn the basics.

FDA Still Hooked on Meddling in Nicotine Markets



FDA launches anti-vaping campaign.

FDA Struggles to Develop “Sugar Added” Labels for Honey and Maple Syrup



An example of sweet intentions bearing stale outcomes.

Let Competition, Not the FDA, Resolve the EpiPen Shortage



The only reliable remedy to mitigate shortages of any product is to allow competition in the market.

Government vs. Private Efforts to Promote Breastfeeding: My Response to a Critic



Private efforts to promote childhood nutrition (specifically breastfeeding) are superior to government “solutions.”

FDA Considers Regulating E-cigarette Juices



Despite the best of intentions, efforts to regulate vice frequently fail and can lead to harmful secondary effects for those they intend to help.

FDA Approves Medical App for Contraception



FDA behind the market in delivering contraceptive apps.

Open Up Off-Label Drug Communication and Let the Market Work!



Off-label information policy reform works to broaden what information drug providers can share.

Three Reasons To Be Optimistic about Pharmaceutical Policy



Right-to-try, MDMA, and Epidolex provide examples of the power of public opinion to change the scope of government.

  • Catalyst
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org